Agency Forms Undergoing Paperwork Reduction Act Review, 68885-68886 [2014-27351]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices
appointment of Performance Review
Board Members be published in the
Federal Register.
The following persons may be named
to serve on the Performance Review
Boards or Panels, which oversee the
evaluation of performance appraisals of
Senior Executive Service members of
the Department of Health and Human
Services.
Employee last name
Downing
Foster
Gabriel
Gentile
Gibson
Gill
Gracia
Gunderson
Haseltine
McCabe
McDaniel
Novy
Potts
Seshamani
Teti
Weber
Ziegler-Ragland
Employee first name
Gregory
Robert
Edward
John
Ventris
John
Nadine
Nancy
Amy
William
Eileen
Steve
Oliver
Meena
Catherine
Mark
Cheryl
Date: November 14, 2014.
John W. Gill,
Deputy Assistant Secretary for Human
Resources.
[FR Doc. 2014–27405 Filed 11–17–14; 11:15 am]
BILLING CODE 4151–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–14ARJ]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Clinic Context Matters Study—New—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention,
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The daily use of specific antiretroviral
medications by persons without HIV
infection, but at high risk of sexual or
injection exposure to HIV, has been
68885
shown to be a safe and effective HIV
prevention method. The Food and Drug
Administration approved the use of
Truvada® for preexposure prophylaxis
PrEP) in July 2012 and CDC has issued
Public Health Service clinical practice
guidelines for its use.
Because approximately 50,000 new
HIV infections continue to occur in the
U.S. each year, with rates of HIV
infection increasing most rapidly for
young MSM and because severe
disparities in HIV infection continue
among African-American men and
women, incorporation of PrEP into HIV
prevention is important. However, as a
prevention tool in very early stages of
introduction and use, there is much we
need to learn about how to implement
PrEP in real-world settings.
CDC is requesting OMB approval to
collect data over a 3-year period that
will be used to conduct research among
clinicians about their knowledge,
attitudes, and practices related to a new
intervention (PrEP) over the period of its
initial introduction in their clinics. The
knowledge gained will be used to refine
measurement instruments and methods
(for example, identify modifications to
questions in the current surveys that are
unclear to participants), develop
training and educational resources and
tools for use by CDC/DHAP (Division of
HIV/AIDS Prevention)-funded partners,
and other organizations supporting
delivery of PrEP in clinical settings. The
project will be conducted in clinics in
each of four cities (Houston, Newark,
Chicago, and Philadelphia) where PrEP
has recently become available at local
community health centers. Once per
year for 3 years, CDC will conduct an
online survey of clinicians at
participating clinics to collect data on
the demographics of the respondents
and their knowledge, attitudes,
practices, and organizational factors
related to PrEP and its delivery in their
clinics. Surveys will be administered
through an online survey Web site.
There are no costs to respondents
other than their time. The total annual
burden hours are 88.
ESTIMATED ANNUALIZED BURDEN HOURS
mstockstill on DSK4VPTVN1PROD with NOTICES
Type of respondent
Form name
Number of
respondents
Number of
responses per
respondent
Average hours
per response
Clinician ...........................................................
Clinician Consent and Interview ....................
175
1
30/60
VerDate Sep<11>2014
16:16 Nov 18, 2014
Jkt 235001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
E:\FR\FM\19NON1.SGM
19NON1
68886
Federal Register / Vol. 79, No. 223 / Wednesday, November 19, 2014 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–27351 Filed 11–18–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–0234]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencyies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
National Ambulatory Medical Care
Survey (NAMCS), (OMB No. 0920–0234
exp. 12/31/2014)—Revision—National
Center for Health Statistics (NCHS),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services, acting
through NCHS, shall collect statistics on
the utilization of health care provided
by non-federal office-based physicians
in the United States. On December 13,
2011, the OMB approved data collection
for three years from 2012 to 2014. This
revision is to request approval to
continue NAMCS data collection
activities for three years from 2015–
2017, make minor modifications to
survey content, and to collect additional
questions on alcohol screening practices
and on provider cultural and linguistic
competence. This notice also covers
potential increases in sample size that
might result due to other future budget
allocations.
The National Ambulatory Medical
Care Survey (NAMCS) has been
conducted intermittently from 1973
through 1985, and annually since 1989.
The purpose of NAMCS, a voluntary
survey, is to meet the needs and
demands for statistical information
about the provision of ambulatory
medical care services in the United
States. Ambulatory services are
rendered in a wide variety of settings,
including physicians’ offices and
hospital outpatient and emergency
departments.
The NAMCS target universe consists
of all office visits made by ambulatory
patients to non-Federal office-based
physicians (excluding those in the
specialties of anesthesiology, radiology,
and pathology) who are engaged in
direct patient care. In 2006, physicians
and mid-level providers (i.e., nurse
practitioners, physician assistants, and
nurse midwives) practicing in
community health centers (CHCs) were
added to the NAMCS sample, and these
data will continue to be collected.
To complement NAMCS data, NCHS
initiated the National Hospital
Ambulatory Medical Care Survey
(NHAMCS, OMB No. 0920–0278) in
1992 to provide data concerning patient
visits to hospital outpatient and
emergency departments. NAMCS and
NHAMCS are the principal sources of
data on ambulatory care provided in the
United States.
The annualized estimated burden of
time is 25,311 hours. There is no cost
to the respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Office-based physicians (Core plus Expansion Sample).
Physician Induction Interview (NAMCS–1) ....
Patient Record form (NAMCS–30) (Physician
abstracts on Web).
Pulling, re-filing medical record forms (FR
abstracts).
Induction Interview—service delivery site
(NAMCS–201).
Induction Interview—Providers ......................
Patient Record form (NAMCS–30) (Provider
abstracts).
Pulling, re-filing medical record forms (FR
abstracts).
Pulling, re-filing medical record forms (FR
abstracts).
mstockstill on DSK4VPTVN1PROD with NOTICES
Community Health Centers (Core plus Expansion Sample).
Re-abstraction study .......................................
VerDate Sep<11>2014
16:16 Nov 18, 2014
Jkt 235001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\19NON1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hours)
5,656
1,131
1
30
45/60
14/60
4,525
30
1/60
1,780
1
20/60
4,005
801
1
30
45/60
14/60
3,204
30
1/60
500
10
1/60
19NON1
]]>Agencies
[Federal Register Volume 79, Number 223 (Wednesday, November 19, 2014)]
[Notices]
[Pages 68885-68886]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27351]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-14ARJ]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Clinic Context Matters Study--New--National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The daily use of specific antiretroviral medications by persons
without HIV infection, but at high risk of sexual or injection exposure
to HIV, has been shown to be a safe and effective HIV prevention
method. The Food and Drug Administration approved the use of
Truvada[supreg] for preexposure prophylaxis PrEP) in July 2012 and CDC
has issued Public Health Service clinical practice guidelines for its
use.
Because approximately 50,000 new HIV infections continue to occur
in the U.S. each year, with rates of HIV infection increasing most
rapidly for young MSM and because severe disparities in HIV infection
continue among African-American men and women, incorporation of PrEP
into HIV prevention is important. However, as a prevention tool in very
early stages of introduction and use, there is much we need to learn
about how to implement PrEP in real-world settings.
CDC is requesting OMB approval to collect data over a 3-year period
that will be used to conduct research among clinicians about their
knowledge, attitudes, and practices related to a new intervention
(PrEP) over the period of its initial introduction in their clinics.
The knowledge gained will be used to refine measurement instruments and
methods (for example, identify modifications to questions in the
current surveys that are unclear to participants), develop training and
educational resources and tools for use by CDC/DHAP (Division of HIV/
AIDS Prevention)-funded partners, and other organizations supporting
delivery of PrEP in clinical settings. The project will be conducted in
clinics in each of four cities (Houston, Newark, Chicago, and
Philadelphia) where PrEP has recently become available at local
community health centers. Once per year for 3 years, CDC will conduct
an online survey of clinicians at participating clinics to collect data
on the demographics of the respondents and their knowledge, attitudes,
practices, and organizational factors related to PrEP and its delivery
in their clinics. Surveys will be administered through an online survey
Web site.
There are no costs to respondents other than their time. The total
annual burden hours are 88.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Type of respondent Form name Number of responses per Average hours
respondents respondent per response
----------------------------------------------------------------------------------------------------------------
Clinician........................... Clinician Consent and 175 1 30/60
Interview.
----------------------------------------------------------------------------------------------------------------
[[Page 68886]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-27351 Filed 11-18-14; 8:45 am]
BILLING CODE 4163-18-P
